Ver­tex claims suc­cess on its non-opi­oid pain drug, push­ing can­di­date in­to piv­otal tri­als

Ver­tex may soon have three irons in the fire in its bid to re­peat the sci­en­tif­ic and fi­nan­cial suc­cess of its block­buster cys­tic fi­bro­sis med­i­cines.

The com­pa­ny on Thurs­day re­leased pos­i­tive re­sults from a pair of Phase II tri­als for its non-opi­oid pro­gram, an­nounc­ing that the ex­per­i­men­tal pill sig­nif­i­cant­ly re­duced pa­tients’ pain com­pared to place­bo in two post-op­er­a­tive tri­als. One tri­al looked at pa­tients who had just re­ceived a bunionec­to­my, the oth­er in pa­tients who re­ceived ab­domino­plas­ty — the med­ical term for a “tum­my tuck.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER